Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pylera Quadruple Therapy vs OAC Triple Therapy in H. Pylori
NCT00669955Phase 3Completed
- Sponsor
- Forest Laboratories
- Start
- Jun 2008
- Primary completion
- Jul 2009
- Modality
- Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 3 trial of bismuth subcitrate potassium + metronidazole + tetracycline hydrochloride in Helicobacter pylori infection, sponsored by Forest Laboratories. Started Jun 2008; status: completed.
02
Drugs
bismuth subcitrate potassium + metronidazole + tetracycline hydrochloride
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT00669955.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00669955.